These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10137063)

  • 1. Strategic management of therapeutic advances: experience with colony-stimulating factors.
    Shane R; Nishimura L
    Hosp Pharm; 1994 Sep; 29(9):824, 826-9. PubMed ID: 10137063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective physician review of orders for colony-stimulating factors.
    Nishimura LY; Shane RR; Saltiel E
    Am J Hosp Pharm; 1992 Nov; 49(11):2722-7. PubMed ID: 1471636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of practice guidelines (Part 1).
    Shane R
    Hosp Formul; 1994 Oct; 29(10):711-4, 718-9. PubMed ID: 10137848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Service plans and clinical interventions targeted by the oncology pharmacist.
    Pon D
    Pharm Pract Manag Q; 1996 Apr; 16(1):18-30. PubMed ID: 10157737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing high cost and biotech drugs: two institutions' perspectives.
    Dana WJ; McWhinney B
    Hosp Formul; 1994 Sep; 29(9):638-45. PubMed ID: 10137060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How a CQI program improved aminoglycoside use in a community hospital.
    Wade WE; McCall CY
    Hosp Formul; 1995 Feb; 30(2):114-6. PubMed ID: 10140350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-focused care from a materials manager perspective.
    Miller MA
    J Healthc Resour Manag; 1995 Feb; 13(2):12-5. PubMed ID: 10142502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-unit pharmacists at 720-bed Saint Francis Medical Center, Peoria.
    Wozniak SC; Kostelecky N; Hoy RH
    Strateg Healthc Excell; 1997 Mar; 10(3):10-2. PubMed ID: 10165572
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacist empowerment: taking practice guidelines to the next level (Part 2).
    Puckett W; Egle L; Galt M
    Hosp Formul; 1994 Nov; 29(11):767-72. PubMed ID: 10138573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven years of experience with a pharmacokinetic service.
    Job ML; Ward ES; Murphy JE
    Hosp Pharm; 1989 Jul; 24(7):512-9, 526. PubMed ID: 10318293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How a collaborative task force can assist in managing biotechnology products.
    MacKinnon GE
    Hosp Formul; 1994 Jul; 29(7):526-30, 533. PubMed ID: 10135146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational effort and CQI program improves ordering of serum digoxin levels.
    Wade WE; McCall CY
    Hosp Formul; 1994 Sep; 29(9):657-9. PubMed ID: 10137062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
    Kearney N; Friese C
    Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF (Granulocyte Colony-Stimulating Factor): follow-up and use in a French University hospital.
    Furet I; Closson V; Madelaine I; Faure P
    Can J Hosp Pharm; 1995 Apr; 48(2):90-7. PubMed ID: 10142843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic management of biotechnology agents.
    Huber SL
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S31-3. PubMed ID: 8362888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.